المؤلفون: Anastasia Skalkou, Konstantinos Avranas, Konstantinos Stavropoulos, Alexandos Manafis, Lars P. Kihm, Georgios Lales, Konstantinos Imprialos

المصدر: Cardiovascular & Hematological Disorders-Drug Targets. 18:94-103

مصطلحات موضوعية: Blood Glucose, endocrine system diseases, medicine.medical_treatment, Type 2 diabetes, Pharmacology, 030226 pharmacology & pharmacy, 01 natural sciences, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Dapagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Canagliflozin, business.industry, Insulin, 010401 analytical chemistry, Hematology, General Medicine, medicine.disease, 0104 chemical sciences, Metformin, Renal glucose reabsorption, Diabetes Mellitus, Type 2, chemistry, Molecular Medicine, Glycated hemoglobin, Cardiology and Cardiovascular Medicine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27372ab545987921c5376e17405740ff
https://doi.org/10.2174/1871529x18666180206160838